{
    "2018-08-01": [
        [
            {
                "time": "",
                "original_text": "[买入评级]小分子靶向药物(医药生物行业)：医保谈判催化 竞争格局生变",
                "features": {
                    "keywords": [
                        "小分子靶向药物",
                        "医药生物行业",
                        "医保谈判",
                        "竞争格局"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}